Navigation Links
NIH turns to crowdsourcing to repurpose drugs
Date:7/16/2014

New Rochelle, NY, July 16, 2014Experimental drugs proven safe but perhaps not sufficiently effective in initial testing or against a first disease target may sit gathering dust on the shelves of pharmaceutical companies. An NIH-sponsored effort based on a crowdsourcing strategy to establish collaborations between industrial and academic partners to test and develop these therapeutic compounds was met with an overwhelming response and has led to clinical testing of a broad range of pilot projects and a newly announced round of funding opportunities. These findings are described in a Review article in the preview issue of the new journal Drug Repurposing, Rescue, and Repositioning, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. The article is available free on the Drug Repurposing, Rescue, and Repositioning website.

Christine M. Colvis, PhD and Christopher P. Austin, MD, National Center for Advancing Translational Sciences, National Institutes of Health (NIH), Bethesda, MD, explain that the Center does not focus on a particular disease or organ system, allowing it to support a broad scope of projects that link indications with unmet medical needs to the mechanisms of action of new drug compounds that are ready to move into patient testing. In the article "The NIH-Industry New Therapeutic Uses Pilot Program: Demonstrating the Power of Crowdsourcing") the authors state that among the new funding opportunity announcements released by the Center in May were 12 therapeutic agents for pediatric indication consideration.

"This article describes not only how targeted crowdsourcing can link up the assets, the know-how, and the creativity that drug repurposing needs, but also how such a program can be organized to serve the best interests of all concerned parties," says journal Editor Hermann Mucke, PhD, H.M. Pharma Consultancy, Vienna, Austria. "Pharmaceutical companies and academia must collaborate to leverage their huge potential synergies in compound re-development, and by arranging and mentoring this pilot program NCATS has firmly established its role as a mediator in drug repurposing."


'/>"/>

Contact: Kathryn Ruehle
kruehle@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert  

Related biology news :

1. New research about facial recognition turns common wisdom on its head
2. Commonly used pesticide turns honey bees into picky eaters
3. NTUs new loo turns poo into power
4. EyeLock Inc. Introduces EyeSwipe Nano TS Iris Scanning Turnstile Solution for Secure Access Control
5. How silver turns people blue
6. Gene find turns soldier beetle defence into biotech opportunity
7. GEOLOGY returns to Naica Cave, Mexico, and extends its reach to Mercury
8. Study turns parasite invasion theory on its head
9. Dance of water molecules turns fire-colored beetles into antifreeze artists
10. UCI research turns the corner on autism
11. AFCEAs Homeland Security Conference Returns To Washington, D.C.
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
NIH turns to crowdsourcing to repurpose drugs
(Date:6/6/2019)... (PRWEB) , ... June 05, 2019 , ... ... role as the exclusive financial advisor to Pathologists Bio-Medical Laboratories (PBM) on its ... a preeminent anatomic pathology platform that provides services to more than one dozen ...
(Date:6/4/2019)... ... 04, 2019 , ... Harper was three years old when her owners took ... which caused painful osteoarthritis in the joints. She was referred to a veterinary ... The surgical specialist, Dr. Christopher Eich of Southern California Veterinary Specialty Hospital , ...
(Date:6/3/2019)... ... ... Stay on top of current hot topics through free webinars presented by ... is free, so be sure to register today to save your place! Participate in ... see our upcoming webinars: , CLINICAL TRIALS , June 10 – A Novel Approach ...
Breaking Biology News(10 mins):
(Date:5/31/2019)... Calif. (PRWEB) , ... May 30, 2019 , ... ... of neurotoxins, is pleased to announce the strategic acquisition of Metabiologics, Inc., a ... The acquisition provides Object exclusive ownership and commercialization rights to a full spectrum ...
(Date:5/22/2019)... ... May 22, 2019 , ... Artemis (formerly Agrilyst), the leading enterprise ... funding round co-led by Astanor Ventures and Talis Capital with ... iSelect Fund . The company has raised $11.75m to date and will use ...
(Date:5/15/2019)... ... May 15, 2019 , ... Milton Hershey School® has named William Charles Ballough ... the biomedical industry, where he is changing lives by creating solutions to global healthcare ... epitomizes the vision of our founders – Milton and Catherine Hershey – who always ...
(Date:5/14/2019)... ... May 13, 2019 , ... Leak Detection ... for the Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries’ is excited to ... aims to improve LDA’s ability to communicate directly with the marketplace; serving as ...
Breaking Biology Technology: